Mesoblast (MESO) EBT Margin Growth (1y) (2015 - 2023)
Powered by 
Analysis
Mesoblast (MESO) EBT Margin Growth (1y) (2015 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 553.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4,709.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 1,076.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1,911.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -392.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,565.00 |
| 10 | Mesoblast | 2.24 Bn | 2.14 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -922,281.00 |
| Mar 31, 2023 | 9,988.00 |
| Dec 31, 2022 | -41,475.00 |
| Sep 30, 2022 | -49,521.00 |
| Jun 30, 2022 | -100,308.00 |
| Mar 31, 2022 | 32,820.00 |
| Dec 31, 2021 | 40,715.00 |
| Sep 30, 2021 | 130,490.00 |
| Mar 31, 2021 | -122,602.00 |
| Dec 31, 2020 | -19,387.00 |
| Sep 30, 2020 | -189,320.00 |
| Mar 31, 2020 | 201,205.00 |
| Dec 31, 2019 | 51,965.00 |
| Sep 30, 2019 | 13,016.00 |
| Jun 30, 2019 | 7,039.00 |
| Mar 31, 2019 | 11,987.00 |
| Dec 31, 2018 | -139,698.00 |
| Sep 30, 2018 | 67,131.00 |
| Jun 30, 2018 | 423,703.00 |
| Mar 31, 2018 | -86,642.00 |